Tocilizumab Preserves Lung Function in Early Systemic Sclerosis
FRIDAY, April 23, 2021 -- Tocilizumab prevents progression of interstitial lung disease in patients with early systemic sclerosis (SSc), according to a study recently published in Arthritis& Rheumatology.
David Roofeh, M.D., from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Actemra | Arthritis | Interstitial Lung Disease | Pharmaceuticals | Rheumatology | Scleroderma | Study